Skip to main content
Professor Michael Loebinger

Professor Michael Loebinger

Consultant respiratory physician, Professor of practice - Respiratory medicine

Professor Michael Loebinger is a consultant respiratory physician at Royal Brompton Hospital and a Professor of practice in Respiratory medicine at Imperial College, London. 

Specialty
Respiratory medicine (lung)
Laboratory medicine
Spoken Languages
English

Biography

Professor Loebinger studied at Cambridge University where he obtained a First class degree in Medical Sciences before completing his clinical training at Oxford University. He then trained in respiratory medicine in London, including at St. Thomas’s, Hammersmith, Charing Cross, St. Mary’s, and Royal Brompton Hospitals.

He was awarded a Medical Research Council Clinical Research Training Fellowship in 2006 for research into the use of adult stem cells in lung disease. This research was performed at UCL and led to a PhD, multiple publications and awards, and significant media interest.

Areas of expertise 

Professor Loebinger is a respiratory consultant with particular expertise in respiratory infections. These include patients with:

  • host defence abnormalities
  • bronchiectasis
  • primary ciliary dyskinesia
  • primary immunodeficiency
  • non-tuberculosis mycobacterial infections
  • cystic fibrosis. 

He also has expertise in tuberculosis (TB), is the Trust TB lead and runs TB outpatient clinics at Chelsea and Westminster Hospital. 

Research interests

He is Professor of Practice (Respiratory Medicine) at Imperial College and his current research aims focus around chronic lung infections, in particular bronchiectasis, pseudomonas and non-tuberculosis mycobacterial infections.

He is currently researching host susceptibility to these infections, in addition to the development of biomarkers and clinical endpoints to assist in their management.

Teaching

Professor Loebinger co-chaired the National bronchiectasis guidelines and co-wrote the European bronchiectasis guidelines and National non-tuberculous mycobacteria guidelines.  He chaired the British Thoracic Society Specialist Advisory Group for respiratory infections (2013-2016) and is presently secretary of the European Respiratory Society respiratory infection group. 

He has helped set up national and European research networks, with funding to produce clinical bronchiectasis databases and is the recipient of several prestigious research grants. He also collaborates with Industry and is global, national and site principal investigator of multi-centre international clinical trials. 

Professor Loebinger supervises PhD students and accepts multiple medical students for research attachments each year. He has been an Imperial College tutor and assessor for higher degrees and an external examiner. He lectures about his clinical specialism and research at national and international meetings and is involved in public and patient education, speaking at patient days and for the British Lung Foundation.

See the full list of his research publications on Imperial's website.  

Awards

He has won young investigator of the year awards from the Royal Society of Medicine, the European Respiratory Society, the British Thoracic Society and the British Association of Lung Research. In addition, he has won prestigious awards from the American Thoracic Society, the Medical Research Society and the British Lung Foundation, and was awarded the European Respiratory Society research award for innovation in non-tuberculous Mycobacteria in 2018.


Private patient referral 

If you would like to make an appointment with this specialist for private care, contact the RB&HH Specialist care team


Research Publications

There is little literature about the mortality associated with bronchiectasis. The aim of the present study was to investigate factors affecting mortality in patients with bronchiectasis.